Search

Your search keyword '"Christos Nikolaou"' showing total 2 results
Start Over Author "Christos Nikolaou" Journal case reports in oncological medicine
2 results on '"Christos Nikolaou"'

1. Prolonged Complete Response in a Patient with Metastatic Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Maintenance with FOLFIRI

Author

Christos Nikolaou, Alexios Matikas, Maria Papavasilopoulou, Dimitris Mavroudis, and Lampros Vamvakas

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Metastatic pancreatic adenocarcinoma confers a poor prognosis. Even with recent advances in the treatment of this disease with the introduction of two modestly effective chemotherapy regimens, complete responses are still very rare. Moreover, there are no published data on how to further manage the patients who achieve a sustained remission following treatment. Herein, we report the case of a patient with metastatic pancreatic adenocarcinoma who achieved a complete response lasting for more than three years after receiving induction chemotherapy with FOLFIRINOX followed by maintenance with FOLFIRI.

Published
2015
Full Text
View/download PDF

2. Prolonged Complete Response in a Patient with Metastatic Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Maintenance with FOLFIRI

Author

Dimitris Mavroudis, Lampros Vamvakas, Christos Nikolaou, Maria Papavasilopoulou, and Alexios Matikas

Subjects
Oncology, medicine.medical_specialty, Chemotherapy, Poor prognosis, business.industry, FOLFIRINOX, medicine.medical_treatment, Induction chemotherapy, Case Report, Disease, Metastatic Pancreatic Adenocarcinoma, Bioinformatics, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Internal medicine, FOLFIRI, Medicine, business, Complete response
Abstract

Metastatic pancreatic adenocarcinoma confers a poor prognosis. Even with recent advances in the treatment of this disease with the introduction of two modestly effective chemotherapy regimens, complete responses are still very rare. Moreover, there are no published data on how to further manage the patients who achieve a sustained remission following treatment. Herein, we report the case of a patient with metastatic pancreatic adenocarcinoma who achieved a complete response lasting for more than three years after receiving induction chemotherapy with FOLFIRINOX followed by maintenance with FOLFIRI.

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results